Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-01-18
2011-01-18
Dentz, Bernard (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S312000, C514S337000, C544S282000, C546S153000, C546S283100
Reexamination Certificate
active
07872011
ABSTRACT:
The present invention relates to selective inhibitors of phosphoinositide (PI) 3-kinase β, use of the selective inhibitors in anti-thrombotic therapy, and a method for screening compounds useful for the new anti-thrombotic therapy by detecting selective inhibitory activity of PI 3-kinase β of the compound. The invention also relates to novel compounds that are inhibitors of PI 3-kinase.
REFERENCES:
patent: 5703075 (1997-12-01), Gammill et al.
patent: 6977255 (2005-12-01), Robertson et al.
patent: 7405211 (2008-07-01), Robertson et al.
patent: 0341104 (1989-11-01), None
patent: WO/9006921 (1990-06-01), None
patent: WO/9119707 (1991-12-01), None
patent: WO/0153266 (2001-07-01), None
Vlahos et al., “A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002),” The Journal of Biological Chemistry (1994) 269(7):5241-5248.
Morris et al., “Synthesis and biological evaluation of antiplatelet 2-aminochromones,” Journal of Medicinal Chemistry (1993) 36(14):2026-2032.
Benjamin et al., “2-Aminochromones block human platelet aggregation by inhibiting cyclic AMP-dependent phosphodiesterase leading to reduced platelet phospholipase C activity,” The Journal of Pharmacology and Experimental Therapeutics (1993) 265(1):457-462.
Benjamin et al., “Inhibition of human platelet aggregation by novel 2-aminochromone phospholipase C inhibitors,” Developments in Oncology (1993) 71:231-233.
STN File CA Abstract Accession No. 139:133525, (2003).
STN File CA Abstract Accession No. 138:287191, (2002).
STN File CA Abstract Accession No. 116:214192, (1992).
STN File CA Abstract Accession No. 63:31556, (1965).
STN File CA Abstract Accession No. 62:49088, (1964).
STN File CA Abstract Accession No. 56:73359, (1961).
STN File CA Abstract Accession No. 48:64297, (1953).
Abbott Belinda
Anderson Karen
Goncalves Isaac
Jackson Shaun P.
Kenche Vijaya
Astrazeneca AB
Dentz Bernard
Pepper Hamilton LLP
LandOfFree
Inhibition of phosphoinositide 3-kinase β does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of phosphoinositide 3-kinase β, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of phosphoinositide 3-kinase β will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2637243